Association of sleep duration with type 2 diabetes and impaired glucose tolerance.
OBJECTIVE
The aim of this study was to assess the relationship between sleep duration and type 2 diabetes or impaired glucose tolerance (IGT).


METHODS
Anthropometric measurements and self-reported sleep duration were determined in a cross-sectional sample of 323 men and 417 women aged 21-64 years from the Quebec Family Study. Glucose homeostasis indicators were compared between short (5-6 h), 'normal' (7-8 h) and long (9-10 h) sleeper groups.


RESULTS
Using adults with 7-8 h of sleep as a reference, the adjusted odds ratio for type 2 diabetes/IGT was 1.58 (1.13-2.31) for those with 9-10 h of sleep and 2.09 (1.34-2.98) for those with 5-6 h of sleep, after adjustment for potential confounding variables. The short and long sleepers presented significantly higher total insulin AUC (p < 0.05), whereas total glucose AUC was not different between the three sleeper groups in both sexes. The mean glucose area below fasting glucose concentrations was significantly higher in short (p < 0.01) and long sleepers (p < 0.05) compared with 'normal' sleepers, and significantly higher in short (p < 0.05) compared with long sleepers in both sexes.


CONCLUSIONS
The present study provides evidence that short- and long-duration sleep times are associated with type 2 diabetes/IGT in adults, even after adjustment for several confounders. These results also showed that the lower glucose concentrations at the end of the OGTT were observed in short sleepers. According to the glucostatic theory of appetite control, this represents a stimulus that can trigger episodes of hunger and spontaneous food intake, which may explain at least in part the greater risk of overweight displayed by short sleepers, as shown in previous studies.
Chaput
J-P
JP
Division of Kinesiology, Department of Social and Preventive Medicine, Faculty of Medicine, Laval University, Quebec City, Quebec, Canada.
Després
J-P
JP
Bouchard
C
C
Tremblay
A
A
D000328:Adult; D019540:Area Under Curve; D001786:Blood Glucose / Q000378:metabolism; D001823:Body Composition; D015992:Body Mass Index; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics / Q000503:physiopathology*; D018149:Glucose Intolerance / Q000235:genetics / Q000503:physiopathology*; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000097:blood; D008875:Middle Aged; D012890:Sleep / Q000502:physiology*; D013997:Time Factors; D044465:White People
D001786:Blood Glucose; D007328:Insulin
Brain Res Bull. 1986 Sep;17(3):427-33
3768746
Sleep. 2004 May 1;27(3):440-4
15164896
Am J Physiol. 1999 Aug;277(2):R337-45
10444538
J Clin Invest. 1949 Jan;28(1):129-39
16695648
Sleep. 1996 Jul;19(6):462-4
8865502
Diabetes Care. 2005 Nov;28(11):2762-7
16249553
Br J Nutr. 1999 Dec;82(6):437-46
10690159
Adv Biol Med Phys. 1956;4:239-80
13354513
Arch Intern Med. 2005 Jan 10;165(1):25-30
15642870
Schweiz Med Wochenschr. 1971 May 1;101(17):615-8
5576952
Diabetologia. 1985 Jul;28(7):412-9
3899825
Neurosci Biobehav Rev. 1996;20(1):133-7
8622819
Sleep. 2004 Jun 15;27(4):661-6
15283000
Sleep. 2005 Oct;28(10):1289-96
16295214
Ann Intern Med. 2004 Dec 7;141(11):846-50
15583226
Diabetes Care. 2006 Mar;29(3):657-61
16505522
Diabetes Care. 1997 Jul;20(7):1183-97
9203460
Sleep. 2004 Feb 1;27(1):51-4
14998237
Lancet. 1999 Oct 23;354(9188):1435-9
10543671
Diabetes Care. 2003 Feb;26(2):380-4
12547866
Arch Intern Med. 2003 Jan 27;163(2):205-9
12546611
Arch Intern Med. 2005 Apr 25;165(8):863-7
15851636
Sleep. 1995 Dec;18(10):908-11
8746400
PLoS Med. 2004 Dec;1(3):e62
15602591
Int J Obes. 1990;14 Suppl 3:15-31; discussion 31-4
2086508
Obesity (Silver Spring). 2007 Jan;15(1):253-61
17228054
Diabet Med. 1998 Jul;15(7):539-53
9686693
J Clin Endocrinol Metab. 1971 Nov;33(5):732-8
5166455
Neurosci Biobehav Rev. 1980;4 Suppl 1:13-5
6765504
N Engl J Med. 1953 Jul 2;249(1):13-6
13063674
J Sleep Res. 1999 Sep;8(3):175-83
10476003
Arch Intern Med. 2006 Sep 18;166(16):1768-74
16983057